AMFI - Registered Mutual Fund Distributor

Mahamaya Lifesciences Limited IPO

Mahamaya Lifesciences Limited IPO

₹ 273600 / 2400 Shares Shares
Minimum Investment

Mahamaya Lifesciences Limited IPO

Issues Price

₹108-114 per equity share

Mahamaya Lifesciences Limited IPO

Open Date

11 Nov 2025

Close Date

13 Nov 2025

Lot Size

1200

Min. Investment

₹ 273600

Issue Price

₹108-114

Listing Date

18 Nov 2025

Issues Size

61,78,800 shares(aggregating up to ₹70.44 crore)

Face Value

₹10 Per Equity Share

Total Shares Offered

2400 Shares

Offered To Public

2400 Shares

Mahamaya Lifesciences Limited IPO

Incorporated in 2002, Mahamaya Lifesciences Limited is engaged in manufacturing, registration, and export of the finest crop protection products and bio-products for crop & soil health management and to help the farming community for more productivity. The company has developed considerable expertise in the manufacture of pesticide formulations and bulk products for Indian agrochemical companies and MNCs.It imports carefully researched molecules, gets them registered with the Central Insecticides Board, and sells them as technical and value-added formulations to domestic manufacturers and MNCs. The company has invested in global product registrations, with active markets including the Dominican Republic, Egypt, Ethiopia, Jordan, UAE, and Turkey, offering high-quality products and data support for registrations.

Founded In

2002

Managing Director

Mr. Krishnamurthy Ganesan

Parent Organization

Mahamaya Lifesciences Limited IPO

Application for Mahamaya Lifesciences Limited IPO

Apply as Price Range Apply Upto
Individual (min) ₹108-114 ₹2,73,600
Individual(max) ₹108-114 ₹2,73,600
SHNI(min) ₹108-114 ₹4,10,400
SHNI(max) ₹108-114 ₹9,57,600
BHNI(min) ₹108-114 ₹10,94,400

Apply for all eligible candidates, Mahamaya Lifesciences Limited IPO

ksquare

Open On12 Dec 2025

Close On16 Dec 2025

Price Range₹2061-2165

ksquare

Open On15 Dec 2025

Close On17 Dec 2025

Price Range₹126

ksquare

Open On12 Dec 2025

Close On16 Dec 2025

Price Range₹135-142

ksquare

Open On11 Dec 2025

Close On15 Dec 2025

Price Range₹94-96

ksquare

Open On11 Dec 2025

Close On15 Dec 2025

Price Range₹112-118

ksquare

Open On10 Dec 2025

Close On12 Dec 2025

Price Range₹12


Testimonial

Genuine Review Form Statisifed Customers

5 Out of 5 (11778 Reviews)

I’m thankful to KSquare for making the NPS onboarding so smooth. Their resources are easy to understand for non-finance people.

Bhavika Thakkar

Bhavika Thakkar

Yoga Instructor

I never thought mutual fund investing could be this simple. KSquare helps me manage risk and meet financial targets effortlessly. Great for working women like me.

Neha Bajaj

Neha Bajaj

Human Resource Lead

I found KSquare’s NFO guides super user-friendly. They cover risks and benefits without overwhelming new investors. Highly recommended for anyone starting out.

Isha Kapoor

Isha Kapoor

Makeup Artist

The NFO section on KSquare is so well designed. I love the simplified jargon and timely alerts before each launch. Great for busy professionals!

Prachi Wadhwa

Prachi Wadhwa

Veterinarian

With KSquare’s help, I finally understood the benefits of NPS. Their team is responsive and really knows their stuff.

Dinesh Rawal

Dinesh Rawal

Transport Manager

Thanks to KSquare, my retirement plan feels organized. Their NPS tools and knowledge gave me real confidence in the future.

Tanya Khosla

Tanya Khosla

PR Consultant

Mutual funds were new to me, but KSquare’s team made sure I understood everything. I now invest regularly with confidence and clarity.

Tanvi Desai

Tanvi Desai

Nutrition Consultant

KSquare’s NRI Corner made investing from abroad incredibly simple. The guidance was crystal clear, and their support team always kept me informed. Highly recommend this service for all NRIs!

Rahul Nanda

Rahul Nanda

IT Consultant

Living overseas, I struggled with Indian investments. KSquare’s NRI Corner fixed that. Their expert advice and ease of access gave me complete peace of mind.

Sneha Kulkarni

Sneha Kulkarni

Healthcare Administrator

KSquare gave me confidence to grow wealth in India from abroad. The onboarding was smooth, and they guided me at every step.

Yash Khanna

Yash Khanna

Engineer

FAQ's

Frequenlty Asked Question

Is it legal for NRIs to invest in Indian markets via KSquare?

Absolutely. KSquare complies with all SEBI and RBI guidelines, ensuring legal and secure investments for NRIs.

Will I still earn returns on pledged mutual funds?

Yes, your mutual fund units continue to generate returns even while they are pledged for a loan.

Can NRIs invest in NPS through KSquare?

Yes, NRIs can invest in NPS if they meet KYC norms. KSquare supports NRI onboarding for NPS accounts.

How does SIP-to-SWP second income planning work?

SIPs help build a corpus first, later converted to monthly withdrawable income through SWP, ensuring reliable financial independence

Can I pause or stop my SIP anytime with KSquare?

Yes, KSquare allows you to pause, stop, or modify your SIP plan anytime through your account dashboard.

How is SIP different from recurring deposits?

Unlike fixed-interest recurring deposits, SIP returns are market-linked and offer higher growth potential with some risk.

Is NPS a good option for retirement planning?

Yes, NPS offers disciplined savings, market-linked returns, and tax benefits, making it a strong choice for long-term retirement planning.

What is a Loan Against Mutual Fund (LAMF)?

A Loan Against Mutual Fund allows you to borrow money by pledging your mutual fund units as collateral without selling your investments.

App Store

Ksquare Timeline Pvt. Ltd. is an AMFI Registered Mutual Fund Distributor having ARN No. 146262. Mutual Fund investments are subject to market risks. Please read all scheme related documents carefully before investing. This website is intended only for informational and self-help purposes and should not be considered as investment advice or return guarantee. Past performance is not indicative of future results. Terms & Conditions apply.